undamentalytics Newsletter
Sign in

Prestige Consumer Healthcare Inc. key statistics and ratios

In fiscal 2026, Prestige Consumer Healthcare Inc. had return on equity of 10.2% and a net margin of 17.5%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Mar 20102011Mar 20112012Mar 20122013Mar 20132014Mar 20142015Mar 20152016Mar 20162017Mar 20172018Mar 20182019Mar 20192020Mar 20202021Mar 20212022Mar 20222023Mar 20232024Mar 20242025Mar 20252026Mar 2026LTMJun 2026
Net margin11.0%8.7%8.4%10.6%12.2%11.0%12.4%7.9%32.6%−3.7%14.8%17.5%18.9%−7.3%18.6%18.9%17.5%15.6%
Return on equity9.8%8.5%9.7%14.9%13.9%13.1%14.6%8.9%33.9%−3.1%12.6%13.0%14.0%−5.4%13.5%12.3%10.2%9.0%
Return on assets—2.8%2.6%3.7%4.1%3.5%3.6%2.0%8.9%−1.0%4.1%4.7%5.8%−2.3%6.3%6.4%5.5%4.3%
Effective tax rate39.2%39.9%39.2%38.2%28.6%38.6%36.4%37.4%——25.6%19.3%21.7%—24.2%24.5%26.1%—
Dividends ÷ net income———0.0%0.0%0.0%0.0%———————————

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

1 of 6 checks passed · June 30, 2026
What it owns · $4.6bn
Short-term assets $497mLonger-term assets $4.1bn
What it owes, and who funded it · $4.6bn
Short-term liabilities $154mLonger-term liabilities $2.5bnShareholders' equity $1.9bn
  • Short-term assets cover short-term liabilities $497m of assets due within a year against $154m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $497m short-term assets against $2.5bn of longer-dated liabilities.
  • More cash than debt $89m of cash against $2.0bn of debt.
  • Debt below 40% of shareholders' equity Debt is 105% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 102% to 105% over five years.
  • A year's operating cash flow covers at least 20% of debt $249m of operating cash flow against $2.0bn of debt.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Prestige Consumer Healthcare Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

67 /100

Moderate moat

How hard Prestige Consumer Healthcare's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 5 / 20

    Net income has been a median 4.7% of total assets over 10 years.

  • Pricing power 19 / 20

    Gross margin has been a median 56.2%, moving by 1.4 percentage points (standard deviation) across 10 years.

  • Durability 10 / 20

    Operating margin has been a median 29.4%; its worst year was -2.1%.

  • Cash conversion 20 / 20

    Free cash flow was positive in 10 of 10 years, at a median 21.3% of revenue.

  • Discipline 18 / 20

    The diluted share count fell 4.8% over five years; stock-based pay has been a median 1.0% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (72 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: PBH vs TRLVANIP vs PBHHRMY vs PBH

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Prestige Consumer Healthcare Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Prestige Consumer Healthcare Inc.